Melatonin Doses in Supplements vs the Data: What 71% to 347% on the Label Means
Lab analyses found gummies and tablets ranging from 71 to 347 percent of their labeled melatonin content — while pediatric ingestions rose five-fold in a decade.
Dietary Supplements
Skincare and haircare examined by formulation: which actives work at which concentrations, how long results take, and where topical treatment stops.
Third-Party Seals on Supplement Labels: What NSF, USP, and Informed Choice Actually Verify
The FDA does not approve supplements before sale — which makes the certification programs, and their very different scopes, the only outside check many products get.
Probiotic Strains, Explained: Which Claims Have Trial Evidence Behind Them
The strongest data sits in antibiotic-associated diarrhea; the weakest sits in the broad immune and mood claims printed across the rest of the shelf.
Collagen Supplements and Skin: What the Clinical Trials Measured, and Who Paid for Them
A 2021 meta-analysis of 19 trials found measurable gains in hydration and elasticity — but nearly every trial tested a manufacturer's own peptide powder for eight to twelve weeks.
Omega-3 Supplements and the Heart: What the Largest Trials Actually Found
VITAL, REDUCE-IT, and STRENGTH enrolled more than 40,000 people between them — and their verdicts on fish-oil capsules diverged in ways that matter on both sides of the pharmacy counter.
Ashwagandha and Stress: What the Randomized Trials Support, and Where the Regulators Object
The adaptogen's trial record is real but small and extract-specific — and a 2023 regulatory suspension in Denmark put liver safety on the label discussion.